Rare diseases
Investigational molecules
Locations
Back to Germany968 clinical trials in Frankfurt, Germany across 7 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study of felzartamab compared to placebo in adults with IgA nephropathy
GermanyStudy of deupsilocin besilate (CYB003) in adults with major depressive disorder comparing two doses against placebo
GermanyStudy of GHZ339 for treatment of moderate to severe atopic dermatitis
GermanyStudy of AP31969 compared to placebo to control heart rhythm in patients with atrial fibrillation
GermanyStudy of drug combination therapy for prevention of recurrent stroke in patients with acute ischemic stroke and atrial fibrillation
GermanyStudy comparing cetuximab with chemotherapy versus bevacizumab with chemotherapy in patients with advanced colorectal cancer who have wild-type RAS and right-sided tumors
GermanyStudy of zoldonrasib with daraxonrasib, pembrolizumab and chemotherapy in patients with RAS G12D-mutant non-small cell lung cancer
GermanyStudy of Dapagliflozin for Reducing Cardiovascular Events in Adults with High Blood Pressure
GermanyStudy of RO7837195 injection compared to placebo to treat moderate to severe ulcerative colitis
GermanyStudy of patritumab deruxtecan versus drug combination in patients with hormone receptor-positive, HER2-negative advanced or metastatic breast cancer
GermanyStudy of Atacicept Treatment for Patients with Multiple Autoimmune Glomerular Diseases
GermanyStudy of Rilvegostomig with Bevacizumab and Tremelimumab as First-line Treatment for Patients with Advanced Liver Cancer
GermanyThe busiest research cities in the country
What the registry says about research in the country
Advanced clinical trials focusing on hematologic malignancies and solid tumors, including innovative treatments for lymphoma, leukemia, and various gastrointestinal cancers.
Studies evaluate novel therapeutic combinations and targeted treatments to improve patient outcomes.
Research initiatives examining treatments for inflammatory bowel conditions, including Crohn's Disease and Ulcerative Colitis, with emphasis on long-term management approaches.
Focus on innovative therapeutic options for chronic inflammatory conditions.
Clinical investigations of treatments for rare conditions, including Von Willebrand Disease and Dravet Syndrome, exploring novel therapeutic approaches.
Development of targeted therapies for previously difficult-to-treat conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
